{"id":66,"date":"2024-09-24T09:28:00","date_gmt":"2024-09-24T07:28:00","guid":{"rendered":"http:\/\/aplusa.local\/?p=66"},"modified":"2026-02-03T17:12:46","modified_gmt":"2026-02-03T16:12:46","slug":"social-media-impact-of-the-eha-2024-hybrid-congress","status":"publish","type":"post","link":"https:\/\/www.aplusaresearch.com\/fr\/perspectives\/social-media-impact-of-the-eha-2024-hybrid-congress\/","title":{"rendered":"Impact des m\u00e9dias sociaux sur le congr\u00e8s hybride EHA 2024"},"content":{"rendered":"

Le congr\u00e8s hybride de l'EHA 2024 (European Hematogoly Association) s'est d\u00e9roul\u00e9 du 13 au 16 juin 2024 \u00e0 Madrid, en Espagne.<\/p>\n\n\n\n

Cette ann\u00e9e, l'\u00e9v\u00e9nement s'est d\u00e9roul\u00e9 principalement en personne, avec des retransmissions virtuelles.<\/p>\n\n\n\n

Le programme en un coup d'\u0153il est disponible ici. Cette analyse des m\u00e9dias sociaux nous permettra d'\u00e9valuer l'impact du congr\u00e8s en ligne.<\/p>\n\n\n\n

Champ d'application<\/h2>\n\n\n\n

L'analyse porte sur les mentions provenant du monde entier*.<\/p>\n\n\n\n

Au total, 8 000 mentions ont \u00e9t\u00e9 enregistr\u00e9es pendant la p\u00e9riode d'\u00e9coute, du 13 juin 2024 au 23 juin 2024 (une semaine avant et deux semaines apr\u00e8s la conf\u00e9rence).<\/p>\n\n\n\n

Toutes les mentions proviennent de X (anciennement connu sous le nom de Twitter).<\/p>\n\n\n\n

Au total, 2 000 auteurs uniques ont \u00e9t\u00e9 identifi\u00e9s.<\/p>\n\n\n\n

*#eha24 OR #eha2024 OR (eha NEAR\/2 (2024 OR 24))<\/p>\n\n\n\n

M\u00e9thodologie<\/h2>\n\n\n\n
\"\"<\/figure>\n\n\n\n

Volume des conversations<\/h2>\n\n\n\n

Le volume global des mentions a consid\u00e9rablement augment\u00e9 par rapport \u00e0 l'ann\u00e9e derni\u00e8re, avec une hausse de 54% par rapport \u00e0 2023. Les professionnels de la sant\u00e9 repr\u00e9sentent le type d'utilisation le plus important par rapport aux organisations et aux entreprises pharmaceutiques et m\u00e9dicales.<\/p>\n\n\n\n

Volume de mentions sur les heures suppl\u00e9mentaires EHA 2023 : HCP<\/strong><\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Top hashtags<\/h2>\n\n\n\n

Le hashtag le plus utilis\u00e9 \u00e9tait lymsm (lymphoma social media).<\/p>\n\n\n\n

\u00c0 noter \u00e9galement, l'utilisation des hashtags #youngeha r\u00e9serv\u00e9s aux membres juniors de l'EHA.<\/p>\n\n\n\n

Le hashtag officiel #eha2024 a \u00e9t\u00e9 le plus utilis\u00e9, la variante #eha24 arrivant en deuxi\u00e8me position.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Les essais cliniques les plus discut\u00e9s<\/h2>\n\n\n\n
\"\"<\/figure>\n\n\n\n

Focus sur le my\u00e9lome multiple : l'essai CASSIOPEIA continue d'impressionner<\/h2>\n\n\n\n

Le suivi \u00e0 long terme de l'essai clinique CASSIOPEIA a \u00e9t\u00e9 pr\u00e9sent\u00e9 lors de l'EHA 2024 et a \u00e9t\u00e9 l'essai clinique le plus mentionn\u00e9 en ce qui concerne le my\u00e9lome multiple.<\/p>\n\n\n\n

Les r\u00e9sultats ont montr\u00e9 que plus de 80% des patients \u00e9taient toujours en vie apr\u00e8s 8 ans dans le bras daratumumab-VTD de l'essai.<\/p>\n\n\n\n

Sujets de discussion (type de traitement)<\/h3>\n\n\n\n
\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n
\"\"<\/figure>\n<\/div>\n<\/div>\n\n\n\n

Volume des mentions<\/h3>\n\n\n\n
\"\"<\/figure>\n\n\n\n

Essais cliniques les plus mentionn\u00e9s<\/h3>\n\n\n\n
\"\"<\/figure>","protected":false},"excerpt":{"rendered":"

The EHA 2024 (European Hematogoly Association) Hybrid Congress took place from June 13th to June 16th, 2024, in Madrid, Spain. This year\u2019s event was primarily an in-person event with virtual broadcasts available. The program at a glance is available here. With this social media analysis, we will be assessing the impact of the congress online. […]<\/p>\n","protected":false},"author":4,"featured_media":7423,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"none","_seopress_titles_title":"","_seopress_titles_desc":"Explore EHA 2024 social media impact: 8K mentions, 54% growth, top hashtags, and CASSIOPEIA trial insights from Madrid.","_seopress_robots_index":"","content-type":"","footnotes":""},"categories":[80],"tags":[],"class_list":{"0":"post-66","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-views"},"acf":[],"_links":{"self":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/posts\/66","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/comments?post=66"}],"version-history":[{"count":0,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/posts\/66\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/media\/7423"}],"wp:attachment":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/media?parent=66"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/categories?post=66"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/tags?post=66"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}